Regulation of human B lymphocyte activation by opioid peptide hormones inhibition of IgG production by opioid receptor class ( μ-, κ-, and δ-) selective agonists

Journal of Neuroimmunology

Volumn 65, Issue 1, 1996, Pages 21-30

  Morgan, Edward L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Antibody; Human lymphocytes; Immunosuppression; Interleukin 6; Opioid receptor agonists

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; IMMUNOGLOBULIN G; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; NORBINALTORPHIMINE; OPIATE AGONIST; OPIATE ANTAGONIST;

ADULT; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ADULT; ANALGESICS; B-LYMPHOCYTES; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; FEMALE; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MALE; OPIOID PEPTIDES; PYRROLIDINES; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; STAPHYLOCOCCUS AUREUS;

EID: 0029877211     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(95)00171-9     Document Type: Article

References (55)

1. Arakawa, K., Akami, T., Okamoto, M., Akioka, K., Nakai, I., Oka, T. and Nagase, H. (1993) Immunosuppression by delta opioid receptor agonists. Transplant. Proc. 25, 738-740.
2. Brown, S.L., Smith, L.R. and Blalock, J.E. (1987) Interleukin 1 and interleukin 2 enhance proopiomelanocortin gene expression in pituitary cells. J. Immunol. 139, 3181-3183.
3. Carr, D.J. (1991) The role of endogenous opioids and their receptors in the immune system. Proc. Soc. Exp. Biol. Med. 198, 710-720.
4. Carr, D.J., Radulescu, R.T., deCosta, B.R., Rice, K.C. and Blalock, J.E. (1990) Differential effect of opioids on immunoglobulin production by lymphocytes isolated from Peyer's patches and spleen. Life Sci. 47, 1059-1069.
5. Carr, D.J., Gebhardt, B.M. and Paul, D. (1993) Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity. J. Pharmacol. Exp. Ther. 264, 1179-1186.
6. Chiappelli, F., Yamashita, N., Faisal, M., Kemeny, M., Bullington, R., Nguyen, L., Clement, L.T. and Fahey, J.L. (1991) Differential effect of beta-endorphin on three human cytotoxic cell populations. Int. J. Immunopharmacol. 13, 291-297.
7. Chang, K.-J., Wei, E.T., Killian, A. and Chang, J.K. (1983) Potent morphicepin analogs: activity relationships and morphine-like activities. J. Pharmacol. Exp. Ther. 227, 403-408.
8. Chao, C.C., Molitor, T.W., Close, K., Hu, S. and Peterson, P.K. (1993) Morphine inhibits the release of tumor necrosis factor in human peripheral blood mononuclear cell cultures. Int. J. Immunopharmacol. 15, 447-453.
9. Chuang, L.F., Chuang, T.K., Killam, K.F., Chuang, A.J., Kung, H.F., Lu, L. and Chuang, R.Y. (1994) Delta opioid receptor gene expression in lymphocytes. Biochem. Biophys. Res. Commun. 202, 1291-1299.
10. De Carolis, C., De Sanctis, G., Perricone, R., Moretti, C., Fabbri, A., Gnessi, L., Fraioli, F. and Fontana, L. (1984) Evidence for an inhibitory role of beta-endorphin and other opioids on human total T rosette formation. Experimenta 40, 738-739.
11. Dixon, W.R., Viveros, O.H., Unsworth, C.D., Diliberto, E.J., Way, E.L., Lewis, A., Chandra, J.W., Holaday, J.B., Long, J.B. and Tortella, F.C. (1985) Multiple opiate receptors: functional implications. Fed. Proc. 44, 2856-2862.
12. Eisenstein, T.K., Bussiere, J.L., Rogers, T.J. and Adler, M.W., (1993) Immunosuppressive effects of morphine on immune responses in mice. Adv. Exp. Med. Biol. 335, 41-52.
13. Fagarasan, M.O., Eskay, R. and Axelrod, J. (1989) Interleukin 1 potentiates the secretion of β-endorphin induced secretagogues in the primary pituitary cell line (AtT-20). Proc. Natl. Acad. Sci. USA 86, 2070-2073.
14. Falkoff, R.J.M., Zhu, L.I. and Fauci, A.S. (1982) Separate signals for human B cell proliferation and differentiation in response to Staphylococcus aureus: evidence for a two-signal model of B cell activation. J. Immunol. 129, 97-102.
15. Farrar, W.L., Hill, J.M., Harel-Bellan, A. and Vincou, M. (1987) The immune logical brain. Immunol. Rev. 100, 361-378.
16. Galin, F.S., LeBoeuf, R.D. and Blalock, J.E. (1990) A lymphocyte mRNA encodes the adrenocorticotropin/beta-lipotropin region of the proopiomelanocortin gene. Prog. Neuroendocrinol. 3, 205-208.
17. Handa, B.K., Lane, A.C., Lord, J.A.H., Morgan, B.A., Rance, M.J. and Smith, C.F.C. (1981) Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors. Eur. J. Pharmacol. 70, 531-540.
18. Heagy, W., Laurance, M., Cohen, E. and Finburg, R. (1990) Neurohormones regulate T cell function. J. Exp. Med. 171, 1625-1633.
19. Heijnen, C.J., Bevers, C., Kavelaars, A. and Ballieux, R.E. (1986) Effects of alpha-endorphin on the antigen-induced primary response of human blood B cells in vitro. J. Immunol. 136, 213-216.
20. 4,Gly-ol]-enkephalin (DAGO). Neuropeptides 5, 383-386.
21. Hucklebridge, F.H., Hudspith, B.N., Muhamed, J., Lydyard, P.M. and Brostoff, J. (1989) Methionine-enkephalin stimulates in vitro proliferation of human peripheral lymphocytes via delta-opioid receptors. Brain Behav. Immun. 3, 183-189.
22. James, I.F. and Goldstein, A. (1984) Site-directed alkylation of multiple opioid receptors. I. Binding selectivity. Mol. Pharmacol. 25, 337-339.
23. Jelinek, D.F. and Lipsky, P.E. (1986) Regulation of human lymphocyte activation. Adv. Immunol. 40, 1-66.
24. Johnson, H.M., Smith, E.M., Torres, B.A. and Blalock, J.E. (1982) Regulation of the in vitro antibody response by neuroendocrine hormones. Proc. Natl. Acad. Sci. USA 79, 4171-4174.
25. Kay, N.E., Morley, J.E. and Allen, J.I. (1990) Interaction between endogenous opioids and IL-2 on PHA-stimulated human lymphocytes. Immunology 70, 485-491.
26. Kishimoto, T. and Hirano, T. (1988) Molecular regulation of B lymphocyte response. Annu. Rev. Immunol. 6, 485-512.
27. Lolait, S.J., Clements, J.A., Markwick, A.J., Cheng, C., McNally, M., Smith, A.I. and Funder, J.W. (1986) Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages. J. Clin. Invest. 77, 1776-1779.
28. Lord, J.A.H., Waterfield, A.A., Hughs, J. and H.W. (1977) Endogenous opioid peptides: multiple agonists and receptors. Nature 267, 495-497.
29. Lotz, M., Jirik, F., Kabouridis, R., Tsoukas, C., Hirano, T., Kishimoto, T. and Carson, D.A. (1988) BSF-2/IL-6 is a costimulant for human thymocytes and T lymphocytes. J. Exp. Med. 167, 1253-1258.
30. Makman, M.H., Bilfinger, T.V. and Stefano, G.B. (1995) Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis. J. Immunol. 154, 1323-1330.
31. Malarkey, W.B. and Zvara, B.J. (1989) Interleukin 1β and other cytokines stimulate adrenocorticotropin release from cultured pituitary cell of patients with Cushing's disease. J. Clin. Endocrinol. Metab. 69, 196-199.
32. Mazumder, S., Nath, I. and Dha, M.M. (1993) Immunomodulation of human T cell responses with receptor selective enkephalins. Immunol. Lett. 35, 33-88.
33. Monstein, H.J., Folksson, J.R. and Terenius, L. (1986) Proenkephalin A-like mRNA in human leukemia lymphocytes and CNS-tissues. Life Sci. 39, 2237-2341.
34. Morgan, E.L. and Weigle, W.O. (1981) Polyclonal activation of human B lymphocytes by Fc fragments. I. Characterization of the cellular requirements for Fc fragment-mediated polyclonal antibody secretion by human peripheral blood B lymphocytes. J. Exp. Med. 154, 778-783.
35. Morgan, E.L., McClurg, M.R. and Janda, J.A. (1990) Suppression of B lymphocyte activation by beta-endorphin. J. Neuroimmunol. 28, 209-217.
36. Mosberg, H.I., Hurst, R., Hruby, V.J., Gee, K., Yamamura, H.I., Galligan, J.J. and Burks, T.F. (1982) Bis-penicillamine enkephalins possess highly improved specificity towards delta-opioid receptors. Proc. Natl. Acad. Sci. USA 80, 5871-5874.
37. Muraguchi, A., Hirano, T., Tang, B., Matsuda, T., Horii, Y., Nakajima, K. and Kishimoto, T. (1988) The essential role of B cell stimulatory factor (BSF-2/IL-6) for the terminal differentiation of B cells. J. Exp. Med. 167, 332-344.
38. Oleson, D.R. and Johnson, D.R. (1988) Regulation of human natural cytotoxicity by enkephalins and selective opiate antagonists. Brain Behav. Immun. 2, 171-186.
39. Peterson, P.K., Sharp, B., Gekker, G., Brummitt, C. and Keane, W.F. (1987a) Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. J. Immunol. 138, 3907-3912.
40. Peterson, P.K., Sharp, B., Gekker, G., Brummitt, C. and Keane, W.F. (1987b) Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells. J. Clin. Invest. 80, 824-831.
41. Portoghese, P.S., Lipkowski, A.W. and Takemori, A.E. (1987) Binaltorphimine and nor-binaltorphimine, potent and selective k-opioid receptor antagonists. Life Sci. 40, 1287-1294.
42. Prieto, J., Subira, M.L., Arroyo, J.L. and Serrano, M. (1989) Opioid peptides modulate the organization of vimentin filaments, phagocytic activity and expression of surface molecules on monocytes. Scand. J. Immunol. 29, 391-398.
43. Rouveix, B. (1992) Opiates and immune function. Consequences on infectious diseases with special references to AIDS. 1992. Therapie 47, 503-512.
44. Scholz, W., McClurg, M.R., Cardenas, G.J., Smith, M., Noonan, D.J., Hugli, T.E. and Morgan, E.L. (1990) C5a-mediated release of interleukin-6 by human monocytes. Clin. Immunol. Immunopathol. 57, 297-307.
45. Sharp, B.M., Tsukayama, D.T., Gekker, G., Keane, W.F. and Peterson, P.K. (1987) Beta-endorphin stimulates polymorphonuclear leukocyte superoxide production via a stereoselective opiate receptor. J. Pharmacol. Exp. Ther. 242, 579-582.
46. Sibinga, N.E.S. and Goldstein, A. (1988) Opioid peptides and opioid receptors in cells of the immune system. Annu. Rev. Immunol. 6, 219-250.
47. Smith, E.M., Harbour-McMenamin, D. and Blalock, J.E. (1985) Lymphocyte production of endorphins and endorphin-mediated immunoregulatory activity. J. Immunol. 135, 779s.
48. Shook, J.E., Kazmierski, W., Wire, W.S., Lemcke, P.K., F., Hruby, V.J. and Burks, T.F. (1988) Opioid receptor selectivity of β-endorphin in vitro and in vivo: mu, delta and epsilon receptors. J. Pharmacol. Exp. Ther. 246, 1018-1025.
49. Taub, D.D., Eisenstein, T.K., Geller, E.B., Adler, M.W. and Rogers, J. (1991) Immunomodulatory activity of m- and k-selective agonists. Proc. Natl. Acad. Sci. USA 88, 360-364.
50. 2. J. Immunol. 1334, 2446-2450.
51. Von Voitlander, P.F., Lahti, R.A. and Lunden, J.H. (1983) U50,488H: a stereoactive and structurally novel non-mu (kappa) opioid agonist. J. Pharmacol. Exp. Ther. 224, 7-14.
52. Weigent, D.A. and Blalock, J.E. (1987) Interactions between the neuroendocrine and immune systems: common hormones and receptors. Immunol. Rev. 100, 79-108.
53. Westly, H.J., Kleiss, A.J., Kelley, K.W., Wong, P.K.Y. and Yuen, P.K. (1986) Newcastle disease virus-infected splenocytes express the proopiomelanocortin gene. J. Exp. Med. 163, 1589-1594.
54. Williamson, S.A., Knight, R.A., Lightman, S.L. and Hobbs, J.R. (1988) Effect of beta-endorphin on specific immune responses in man. Immunology 65, 47-51.
55. Zurawski, G., Bebedik, M., Kamb, B.J., Abrams, J.S., Zurawski, S.M. and Lee, F.D. (1986) Activation of mouse T-helper cells induce abundant preproenkephalin mRNA synthesis. Science 232, 772-775.